Free Trial
→ The End of Elon Musk…? (From Brownstone Research) (Ad) Free FNCH Stock Alerts

Finch Therapeutics Group (FNCH) Short Interest Ratio & Short Volume

Finch Therapeutics Group logo
$12.50 0.00 (0.00%)
As of 01:37 PM Eastern
Compare

Finch Therapeutics Group Short Interest Data

Finch Therapeutics Group (FNCH) has a short interest of 100 shares, representing 0.01% of the float (the number of shares available for trading by the public). This marks a -88.89% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 2,097 shares to cover all short positions.

Current Short Interest
100 shares
Previous Short Interest
900 shares
Change Vs. Previous Month
-88.89%
Dollar Volume Sold Short
$1.32 thousand
Short Interest Ratio
0.0 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
1,606,000 shares
Short Percent of Float
0.01%
Today's Trading Volume
1,390 shares
Average Trading Volume
2,097 shares
Today's Volume Vs. Average
66%
Short Selling Finch Therapeutics Group?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Finch Therapeutics Group and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

FNCH Short Interest Over Time

FNCH Days to Cover Over Time

FNCH Percentage of Float Shorted Over Time

Finch Therapeutics Group Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/2025100 shares $1.32 thousand -88.9%0.0%0 $13.20
6/15/2025900 shares $12.38 thousand No Change0.1%0.6 $13.75
5/31/2025900 shares $12.15 thousand +12.5%0.1%0.3 $13.50
5/15/2025800 shares $10.57 thousand -11.1%N/A0.2 $13.21
4/30/2025900 shares $11.25 thousand -18.2%N/A0.1 $12.50
4/15/20251,100 shares $14.63 thousand -31.3%N/A0.3 $13.30
3/14/20251,600 shares $21.84 thousand No ChangeN/A0.3 $13.65
2/28/20251,600 shares $25.26 thousand -36.0%N/A0.4 $15.79
2/14/20252,500 shares $37.50 thousand +66.7%N/A0.3 $15.00
1/31/20251,500 shares $16.88 thousand No ChangeN/A0.8 $11.25
1/15/20251,500 shares $16.37 thousand -6.3%N/A0.9 $10.91
5/15/202419,200 shares $40.32 thousand -27.3%2.8%0.3 $2.10
4/30/202426,400 shares $61.78 thousand +149.1%4.9%0.5 $2.34
4/15/202410,600 shares $23.80 thousand +15.2%2.0%0.2 $2.25
3/31/20249,200 shares $23.92 thousand -20.7%1.7%0.5 $2.60
3/15/202411,600 shares $29.64 thousand +383.3%2.2%0.6 $2.56
2/29/20242,400 shares $6.24 thousand -27.3%0.5%0.1 $2.60
2/15/20243,300 shares $8.25 thousand +65.0%0.6%0.1 $2.50
1/31/20242,000 shares $5.50 thousand +300.0%0.4%0.1 $2.75
1/15/2024500 shares $1.56 thousand -73.7%0.1%0 $3.11
12/31/20231,900 shares $6.86 thousand -65.5%0.4%0.1 $3.61
12/15/20235,500 shares $18.92 thousand -61.3%1.0%0.3 $3.44
11/30/202314,200 shares $61.06 thousand -27.9%2.5%1.7 $4.30
11/15/202319,700 shares $79.00 thousand -3.9%3.4%2.8 $4.01
10/31/202320,500 shares $79.54 thousand -11.6%3.6%2.8 $3.88
10/15/202323,200 shares $103.94 thousand -4.1%4.1%2.6 $4.48
9/30/202324,200 shares $125.36 thousand -15.1%4.3%2.5 $5.18
9/15/202328,500 shares $163.59 thousand +27.2%5.1%2.7 $5.74
8/31/202322,400 shares $144.70 thousand +4.7%4.0%0.6 $6.46
8/15/202321,400 shares $133.96 thousand +57.4%3.8%0.6 $6.26
7/31/202313,600 shares $104.18 thousand -20.0%0.1%0.4 $7.66
7/15/202317,000 shares $155.89 thousand -25.4%0.1%0.5 $9.17
6/30/202322,800 shares $194.48 thousand -20.8%4.0%0.6 $8.53
6/15/202328,800 shares $249.12 thousand -73.1%5.1%0.8 $8.65
5/31/2023106,900 shares $897.96 thousand +73.5%0.6%0.4 $8.40
5/15/202361,600 shares $22.27 thousand -73.3%0.4%0.2 $0.36
4/30/2023230,300 shares $92.86 thousand +83.1%1.4%0.8 $0.40
4/15/2023125,800 shares $49.36 thousand +47.0%0.7%0.4 $0.39
3/31/202385,600 shares $33.64 thousand -9.9%0.5%0.5 $0.39
3/15/202395,000 shares $35.15 thousand -51.7%0.6%0.5 $0.37
“All the land that you see I will give to you and your offspring forever…” (Ad)

“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.

Watch Jim Rickards reveal the Old Testament Wealth Code
2/28/2023196,500 shares $81.35 thousand +10.2%1.2%1.2 $0.41
2/15/2023178,400 shares $75.12 thousand +49.8%1.1%1.1 $0.42
1/31/2023119,100 shares $59.55 thousand -4.4%0.7%0.9 $0.50
1/15/2023124,600 shares $69.78 thousand +22.4%0.8%1.2 $0.56
12/30/2022101,800 shares $48.86 thousand +27.4%0.6%1.4 $0.48
12/15/202279,900 shares $64.71 thousand +6.4%0.5%1.3 $0.81
11/30/202275,100 shares $73.61 thousand -17.7%0.5%1.8 $0.98
11/15/202291,300 shares $98.44 thousand -17.9%0.6%2.1 $1.08
10/31/2022111,200 shares $144.56 thousand -6.1%0.7%2.5 $1.30
10/15/2022118,400 shares $188.26 thousand -21.0%0.7%2.6 $1.59
9/30/2022149,900 shares $250.33 thousand +19.6%1.0%3.2 $1.67
9/15/2022125,300 shares $334.55 thousand -12.7%0.8%2 $2.67
8/31/2022143,600 shares $310.18 thousand -37.9%1.0%2 $2.16
8/15/2022231,400 shares $647.92 thousand -19.6%1.5%2.8 $2.80
7/31/2022287,700 shares $561.02 thousand +0.6%1.9%2.4 $1.95
7/15/2022285,900 shares $651.85 thousand -24.5%1.9%0.3 $2.28
6/30/2022378,600 shares $1.08 million -41.3%2.5%0.4 $2.84
6/15/2022644,700 shares $1.75 million -14.1%4.3%0.7 $2.71
5/31/2022750,800 shares $1.78 million -0.6%5.0%0.8 $2.37
5/15/2022755,200 shares $1.68 million +296.0%5.0%0.8 $2.23
4/30/2022190,700 shares $482.47 thousand +2.3%1.3%0.2 $2.53
4/15/2022186,500 shares $760.92 thousand -13.1%1.2%5.3 $4.08
3/31/2022214,500 shares $1.08 million -9.0%1.4%6.3 $5.03
3/15/2022235,700 shares $1.22 million -6.5%1.6%5.7 $5.17
2/28/2022252,200 shares $2.11 million -0.4%1.7%3.5 $8.37
2/15/2022253,100 shares $2.21 million -0.5%1.7%3 $8.75
1/31/2022254,300 shares $2.16 million +9.9%1.5%2.5 $8.48
1/15/2022231,400 shares $2.11 million -8.9%1.4%2.1 $9.10
12/31/2021253,900 shares $2.53 million +58.1%1.5%2.3 $9.97
12/15/2021160,600 shares $1.52 million -30.5%1.0%1.5 $9.47
11/30/2021231,100 shares $3.84 million +22.5%1.4%2.9 $16.62
11/15/2021188,700 shares $2.74 million +0.4%1.1%3.1 $14.54
10/29/2021187,900 shares $2.52 million -19.1%1.1%4 $13.40
10/15/2021232,200 shares $2.77 million -2.6%1.4%6.8 $11.95
9/30/2021238,300 shares $3.10 million -2.4%1.4%5 $13.00
9/15/2021244,100 shares $3.38 million -16.6%1.5%3.7 $13.83
8/31/2021292,800 shares $4.14 million -31.0%1.8%4 $14.15
8/13/2021424,600 shares $5.58 million No Change2.5%5.7 $13.15

FNCH Short Interest - Frequently Asked Questions

What is Finch Therapeutics Group's current short interest?

Short interest is the volume of Finch Therapeutics Group shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 100 shares of FNCH short. 0.01% of Finch Therapeutics Group's shares are currently sold short. Learn More on Finch Therapeutics Group's current short interest.

What is a good short interest percentage for Finch Therapeutics Group?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of Finch Therapeutics Group's floating shares are currently sold short.

Is Finch Therapeutics Group's short interest increasing or decreasing?

Finch Therapeutics Group saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 100 shares, a decrease of 88.9% from the previous total of 900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Finch Therapeutics Group's short interest compare to its competitors?

0.01% of Finch Therapeutics Group's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Finch Therapeutics Group: Entera Bio Ltd. (0.14%), IGM Biosciences, Inc. (2.36%), Quince Therapeutics, Inc. (1.29%), Immix Biopharma, Inc. (1.00%), Immunic, Inc. (9.79%), Connect Biopharma Holdings Limited Sponsored ADR (0.07%), Oncobiologics, Inc. (8.29%), Verrica Pharmaceuticals Inc. (0.43%), Adaptimmune Therapeutics PLC (1.84%), Milestone Pharmaceuticals Inc. (4.58%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Finch Therapeutics Group stock?

Short selling FNCH is an investing strategy that aims to generate trading profit from Finch Therapeutics Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Finch Therapeutics Group?

A short squeeze for Finch Therapeutics Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FNCH, which in turn drives the price of the stock up even further.

How often is Finch Therapeutics Group's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FNCH, twice per month. The most recent reporting period available is June, 30 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:FNCH) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
FREE BUY ALERT: These 3 tiny AI stocks could surge
We're living in unprecedented times. Most people think it's too late to get into AI right now … That the...
Weiss Ratings | Sponsored
Will I be blacklisted?
Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...
Porter & Company | Sponsored
When your faith is put to the test, what will you do?
Former CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 tr...
Paradigm Press | Sponsored